You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 17, November 5, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •JAMA Report Video
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Oncology, Other
 •Cardiovascular System
 •Women's Health
 •Women's Health, Other
 •Randomized Controlled Trial
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Combined Folic Acid, Vitamin B6, and Vitamin B12 on Cancer Risk in Women

A Randomized Trial

Shumin M. Zhang, MD, ScD; Nancy R. Cook, ScD; Christine M. Albert, MD, MPH; J. Michael Gaziano, MD, MPH; Julie E. Buring, ScD; JoAnn E. Manson, MD, DrPH

JAMA. 2008;300(17):2012-2021.

Context  Folate, vitamin B6, and vitamin B12 are thought to play an important role in cancer prevention.

Objective  To evaluate the effect of combined folic acid, vitamin B6, and vitamin B12 treatment on cancer risk in women at high risk for cardiovascular disease.

Design, Setting, and Participants  In the Women's Antioxidant and Folic Acid Cardiovascular Study, 5442 US female health professionals aged 42 years or older, with preexisting cardiovascular disease or 3 or more coronary risk factors, were randomly assigned to receive either a daily combination of folic acid, vitamin B6, and vitamin B12 or a matching placebo. They were treated for 7.3 years from April 1998 through July 31, 2005.

Intervention  Daily supplementation of a combination of 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12 (n = 2721) or placebo (n = 2721).

Main Outcome Measures  Confirmed newly diagnosed total invasive cancer or breast cancer.

Results  A total of 379 women developed invasive cancer (187 in the active treatment group and 192 in the placebo group). Compared with placebo, women receiving the active treatment had similar risk of developing total invasive cancer (101.1/10 000 person-years for the active treatment group vs 104.3/10 000 person-years for placebo group; hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.79-1.18; P = .75), breast cancer (37.8/10 000 person-years vs 45.6/10 000 person-years, respectively; HR, 0.83; 95% CI, 0.60-1.14; P = .24), or any cancer death (24.6/10 000 person-years vs 30.1/10 000 person-years, respectively; HR, 0.82; 95% CI, 0.56-1.21; P = .32).

Conclusion  Combined folic acid, vitamin B6, and vitamin B12 treatment had no significant effect on overall risk of total invasive cancer or breast cancer among women during the folic acid fortification era.

Trial Registration  clinicaltrials.gov Identifier: NCT00000541


Author Affiliations: Divisions of Preventive Medicine (Drs Zhang, Cook, Albert, Gaziano, Buring, and Manson) and Aging (Drs Gaziano and Buring), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Department of Epidemiology, Harvard School of Public Health (Drs Cook, Buring, and Manson); Veterans Affairs Boston Healthcare System (Dr Gaziano); and Department of Ambulatory Care and Prevention, Harvard Medical School (Dr Buring), Boston, Massachusetts.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Should We Manage Patients With Non-ST Segment Elevation Myocardial Infarction With Renal Failure With an Invasive Strategy?
Cannon
Circulation 2009;120:828-830.
FULL TEXT  

Nutritional Prevention of Cancer: New Directions for an Increasingly Complex Challenge
Kristal and Lippman
JNCI J Natl Cancer Inst 2009;101:363-365.
FULL TEXT  

Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk
Maruti et al.
Am. J. Clin. Nutr. 2009;89:624-633.
ABSTRACT | FULL TEXT  

Vitamin Supplements and Cancer Prevention: Where Do Randomized Controlled Trials Stand?
Albanes
JNCI J Natl Cancer Inst 2009;101:2-4.
FULL TEXT  

No Easy Way: B Vitamins Don't Prevent Cancer in Everyone
JWatch Women's Health 2008;2008:4-4.
FULL TEXT  

Vitamin B and Cancer Risk in Women
JWatch General 2008;2008:2-2.
FULL TEXT  

All you need to read in the other general journals
BMJ 2008;337:a2463-a2463.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.